TrialKey is an AI-driven clinical trial predictor with the highest accuracy rate in the market to date at +90%*. The platform provides users access to tailored, actionable steps to address critical trial challenges, improving the likelihood of success as quickly as possible and at lower costs.

By harnessing the power of AI and machine learning, we deliver customized recommendations that help streamline trial design, execution, and drug mechanism of action.

Drawing on an extensive dataset spanning over 20 years and encompassing more than 65,000 clinical trials, TrialKey employs AI and GPT-4 to analyze real-world trial data based on over 700 variables. It provides users with:

• An estimate of a clinical trial’s probability of success
• Actionable insights aimed at enhancing every facet of trial design
• Advanced clinical trial search, sorting, and filtering functions facilitating the swift identification of relevant trials and their closest competitors
• An overview of promising areas of research
• Detailed timelines of ongoing trials for an area of research